1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl-rac-glycerol
- $61 - $261
- Product name: 1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl-rac-glycerol
- CAS: 960594-33-6
- MF: C43H72O5
- MW: 669.03
- EINECS:
- MDL Number:
- Synonyms:1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl-rac-glycerol;1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl Glycerol;(cis-11,14,17) 1,3-Dieicosatrienoin;11,14,17-Eicosatrienoic acid, 1,1'-(2-hydroxy-1,3-propanediyl) ester, (11Z,11'Z,14Z,14'Z,17Z,17'Z)-;(11Z,11'Z,14Z,14'Z,17Z,17'Z)-11,14,17-eicosatrienoic acid, 1,1'-(2-hydroxy-1,3-propanediyl) ester;1,3-Dieicosatrienoin
3 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 10mg
- 25mg
- 50mg
- ManufacturerCayman Chemical
- Product number26938
- Product description1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl Glycerol
- Packaging10mg
- Price$61
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number26938
- Product description1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl Glycerol
- Packaging25mg
- Price$139
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number26938
- Product description1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl-rac-glycerol
- Packaging50mg
- Price$261
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 26938 | 1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl Glycerol | 10mg | $61 | 2024-03-01 | Buy |
Cayman Chemical | 26938 | 1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl Glycerol | 25mg | $139 | 2024-03-01 | Buy |
Cayman Chemical | 26938 | 1,3-Di-11(Z),14(Z),17(Z)-Eicosatrienoyl-rac-glycerol | 50mg | $261 | 2024-03-01 | Buy |
Properties
Boiling point :714.6±55.0 °C(Predicted)
Density :0.949±0.06 g/cm3(Predicted)
solubility :Chloroform: soluble
form :A liquid
pka :12.63±0.20(Predicted)
Density :0.949±0.06 g/cm3(Predicted)
solubility :Chloroform: soluble
form :A liquid
pka :12.63±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|